UNSPSC 85612904: Revision of intraluminal device in pancreas, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of intraluminal device in pancreas, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FWG0DZ

UNSPSC 85612904 Revision of intraluminal device in pancreas, open approach is a Commodity code whose nominal title reflects a specific surgical procedure, but recent state and local procurement activity under this code bears no meaningful connection to pancreatic intervention. The six recent opportunities posted across state and local jurisdictions involve occupational medical surveillance, independent disability medical evaluations, surgical benefit carve-out network administration, pharmacy benefit management, temporary health professional staffing, and emergency medical services for youth in custody — none of which align with the code's stated scope of pancreatic device revision. The misalignment suggests either that the code has been incorrectly assigned to these opportunities by issuing bodies or that the code itself does not accurately reflect state and local buying patterns in this taxonomy tier.

State and local procurement activity under this code shows negligible relevant volume. No recent opportunities specifically procure intraluminal pancreatic devices, related supplies, or surgical services for pancreatic intervention. The Washington State Department of Transportation, City of Phoenix, City of Long Beach, Collier County, Santa Clara County Health System, and Harris County Juvenile Probation Department have posted solicitations tagged to this code, but their actual needs span entirely different commodity families — benefits administration, staffing, and occupational health services. Without recent opportunities that genuinely involve pancreatic device procurement or related services, this code presents no actionable market signal for business development targeting state and local pancreatic intervention or device-related products and services.